New Consensus Statement Updates Guidelines For Cardiac Device Lead Management

Over nan past 70 years, CIEDs person go an established curen action for selected patients pinch bradycardia, tachycardia, and bosom failure. It is estimated that successful 2022, 800,000 CIEDs were implanted successful nan United States. Future CIED implant rates are expected to beryllium higher owed to nan world aging population, peculiarly for imperishable pacemakers.

CIEDs traditionally usage leads that link nan beat generator to cardiac tissue. Since nan publication of nan "2017 HRS Expert Consensus Statement connected Cardiovascular Implantable Electronic Device Lead Management and Extraction," nan section has evolved quickly pinch nan publication of caller grounds connected CIED transvenous lead management, improvement of caller CIED technologies that are leadless aliases usage leads implanted extracurricular nan vascular system, wide take of leads that do not person a lumen, caller lead extraction tools, and caller cardiac and vascular procedures that person lead guidance implications.

The statement statement's penning committee consisted of internationally recognized experts from 5 countries successful nan fields of objective electrophysiology, pediatric electrophysiology, cardiothoracic anesthesiology, cardiothoracic surgery, and infectious diseases representing aggregate master societies. They systematically reviewed technological grounds and translated their findings into recommendations to amended nan value of attraction successful CIED lead management. This existent master statement connection focuses connected providing an update connected applicable objective guidance successful nan wide section of lead management, including extraction and guidance of accepted CIEDs that usage transvenous leads, CIEDs pinch extravascular aliases subcutaneous leads, and leadless CIEDs.

The caller recommendations reside nan latest CIED technologies pinch advantages complete transvenous leads, caller grounds supporting diagnosis, treatment, and prevention for CIED infection, due lead guidance successful transcatheter tricuspid valve replacement for tricuspid regurgitation, and standardization of transvenous lead extraction approach, protocol, and accommodation to amended nan outcomes of CIED lead guidance and extraction.

"Newer technologies successful CIED connection nan imaginable to alteration nan objective challenges and morbidity associated pinch intravascular devices. Since nan 2017 statement statement, nan usage of leadless pacing and non-vascular implantable cardioverter defibrillators has accrued substantially, ushering successful a caller paradigm of non-vascular cardiac hit management," says Dr. Cha.

She concludes, "Future lead guidance considerations must beryllium taken into relationship erstwhile immoderate CIED—including leadless pacemakers—is implanted. At first CIED implant aliases subsequently erstwhile a generator aliases lead needs to beryllium replaced aliases revised, instrumentality prime and lead guidance issues see objective indication, diligent comorbidities, predicted diligent lifespan, lead performance, consequences of immoderate early CIED complication, and imaginable objective use and risks. This collaborative attack ensures that instrumentality and lead action and guidance strategies align pinch nan patient's semipermanent health, individual preferences, and value of life to optimize outcomes complete time."

Source:

Journal reference:

Cha, Y.-M., et al. (2026). 2026 HRS/AHA/APHRS/EHRA/IDSA/LAHRS/PACES/STS master statement connection update connected cardiovascular implantable physics instrumentality lead guidance and extraction. Heart Rhythm. DOI: 10.1016/j.hrthm.2026.04.015. https://www.heartrhythmjournal.com/article/S1547-5271(26)02264-2/pdf